Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-19

FDA Approved: PREGABALIN — Original Application (ScieGen Pharmaceuticals, Inc)

View source ↗

Summary

FDA approves ScieGen Pharmaceuticals' original application for pregabalin (generic pregabalin), enabling the generic product to be marketed in the United States…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

ORIG AP for PREGABALIN (PREGABALIN)